| パッケージ | 価格 | 錠剤 | 節約 | ご注文 |
|---|---|---|---|---|
| 6mg × 10 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | お買物かごに入れる | |
| 6mg × 20 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | - | お買物かごに入れる |
| 6mg × 30 tablet | ¥ 9284.62 錠剤 ¥ 309.49 | ¥ 309.49 | - | お買物かごに入れる |
| 6mg × 60 tablet | ¥ 11607.71 錠剤 ¥ 193.46 | ¥ 193.46 | - | お買物かごに入れる |
| 6mg × 90 tablet | ¥ 13930.80 錠剤 ¥ 154.79 | ¥ 154.79 | - | お買物かごに入れる |
| 6mg × 120 tablet | ¥ 15479.53 錠剤 ¥ 129.00 | ¥ 129.00 | - | お買物かごに入れる |
| 6mg × 180 tablet | ¥ 20125.71 錠剤 ¥ 111.81 | ¥ 111.81 | - | お買物かごに入れる |
| パッケージ | 価格 | 錠剤 | 節約 | ご注文 |
|---|---|---|---|---|
| 24mg × 12 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | お買物かごに入れる | |
| 24mg × 24 tablet | ¥ 20125.71 錠剤 ¥ 838.57 | ¥ 838.57 | - | お買物かごに入れる |
| 24mg × 36 tablet 無料航空便配送 | ¥ 29418.07 錠剤 ¥ 817.17 | ¥ 817.17 | - | お買物かごに入れる |
| 24mg × 60 tablet 無料航空便配送 | ¥ 46454.07 錠剤 ¥ 774.23 | ¥ 774.23 | - | お買物かごに入れる |
| 24mg × 90 tablet 無料航空便配送 | ¥ 67361.88 錠剤 ¥ 748.47 | ¥ 748.47 | - | お買物かごに入れる |
| 24mg × 120 tablet 無料航空便配送 | ¥ 85172.24 錠剤 ¥ 709.77 | ¥ 709.77 | - | お買物かごに入れる |
| パッケージ | 価格 | 錠剤 | 節約 | ご注文 |
|---|---|---|---|---|
| 30mg × 12 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | お買物かごに入れる | |
| 30mg × 24 tablet 無料航空便配送 | ¥ 24771.89 錠剤 ¥ 1032.16 | ¥ 1032.16 | - | お買物かごに入れる |
| 30mg × 36 tablet 無料航空便配送 | ¥ 35612.98 錠剤 ¥ 989.25 | ¥ 989.25 | - | お買物かごに入れる |
| 30mg × 60 tablet 無料航空便配送 | ¥ 55746.43 錠剤 ¥ 929.11 | ¥ 929.11 | - | お買物かごに入れる |
| 30mg × 90 tablet 無料航空便配送 | ¥ 77428.61 錠剤 ¥ 860.32 | ¥ 860.32 | - | お買物かごに入れる |
Deflazacort tablets
What is this medicine?
Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
What should I tell my health care providers before I take this medicine?
They need to know if you have any of these conditions:
- Hypersensitivity to deflazacort;
- Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
- Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
- Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
- Gastrointestinal Perforation: GI disorders;
- Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
- Effects on Bones: decreases in bone mineral density;
- Serious Skin Rashes;
- Ophthalmic Effects: May include cataracts, infections, and glaucoma;
- Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.
How should I use this medicine?
The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..
What may interact with this medicine?
- Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
- Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.
What side effects may I notice from this medicine?
The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.